A61N 1/36121
Production of neurotransmitters
Official title: {Production of neurotransmitters; Modulation of genes expression}
A61N1/36121 (Production of neurotransmitters) appears on 77 US grants and 120 published applications in this corpus.
Search patents in A61N- Granted patents
- 77
- Published applications
- 120
- Assignees
- 56
- Inventors
- 185
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 4 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 4 |
| 2011 | 1 | 3 |
| 2012 | 1 | 2 |
| 2013 | 3 | 5 |
| 2014 | 7 | 4 |
| 2015 | 0 | 4 |
| 2016 | 4 | 6 |
| 2017 | 7 | 8 |
| 2018 | 2 | 7 |
| 2019 | 8 | 8 |
| 2020 | 6 | 12 |
| 2021 | 6 | 9 |
| 2022 | 6 | 13 |
| 2023 | 6 | 7 |
| 2024 | 7 | 9 |
| 2025 | 9 | 9 |
| 2026 | 3 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modulation of brain-derived neurotrophic factor (BDNF)2 Jun 2026US 12,642,967 B2Leonhardt Ventures LLC
- Systems and methods for stimulating the pituitary gland or the pituitary stalk21 Apr 2026US 12,605,546 B2Academisch Ziekenhuis Leiden (H.O.D.N. Lumc)
- Neuromodulation techniques31 Mar 2026US 12,589,262 B2GE Precision Healthcare LLC
- Method and apparatus for multi modal electrical modulation of pain using composite electromagnetic fields23 Dec 2025US 12,502,540 B2Medtronic SG, LLC
- Monitoring of neuromodulation using biomarkers9 Dec 2025US 12,491,364 B2Medtronic Ireland Manufacturing Unlimited Company
- Systems and methods for stimulating the pituitary gland or the pituitary stalk30 Jul 2026US 2026/0216512 A1Academisch Ziekenhuis Leiden (H.O.D.N. Lumc)
- Intra-luminal medical device with evoked biopotential sensing capability5 Feb 2026US 2026/0034364 A1Medtronic, Inc.
- Implantable device systems for sleep apnea5 Feb 2026US 2026/0034369 A1
- Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods15 Jan 2026US 2026/0014377 A1Nevro Corporation
- Closed-loop feedback and treatment11 Sep 2025US 2025/0281753 A1Medtronic, Inc.
Most cited
By later US patents
- Methods and apparatus for intravascularly-induced neuromodulation492US 7,756,583 B2Ardian, Inc. · 2010
- Blood glucose level control85US 8,700,161 B2Metacure Limited · 2014
- Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods60US 9,833,614 B1Nevro Corporation · 2017
- Methods for intravascularly-induced neuromodulation50US 8,818,514 B2Medtronic Ardian Luxembourg S.a.r.l. · 2014
- Methods for therapeutic renal neuromodulation45US 9,439,726 B2Medtronic Ardian Luxembourg S.a.r.l. · 2016